Latest Xolair news
Omalizumab, Multiallergen OIT Both Viable for Multifood Allergy Treatment
posted August 3rd
by modernClinician Editorial Team
by modernClinician Editorial Team
AAAAI: Omalizumab as Effective as Multifood Oral Immunotherapy for Individuals With Food Allergy
posted March 6th
by modernClinician Editorial Team
by modernClinician Editorial Team
Recommendations Developed for Optimizing Biologics in Adults With Severe Asthma
posted January 22nd
by modernClinician Editorial Team
by modernClinician Editorial Team
Omalizumab Protects Against Early, Late Allergic Responses
posted June 8th
by modernClinician Editorial Team
by modernClinician Editorial Team
For patients with a significant response to allergen challenge, omalizumab induces protective effects against early and late allergic reactions, according to a study published online June 5 in Allergy.
Editor's Recommendations
Congenital Ichthyosis Linked to Allergic Disorders 
Distinct Skin Microbiome Features Emerge Before Atopic Disease Onset in Infants 
Exacerbation Risk Profiles Vary With House Dust Mite Sensitization in Pediatric Asthma 
Eosinophilic Esophagitis Prevalence May Be Higher Than Thought in Pediatric Patients With Asthma 
People With ADHD Experience 50 Percent More GI Symptoms 
Relapse Rare After Appendiceal Adenocarcinoma Resection 
U.S. Adults May Not Understand Their Risk for Vascular Disease 
Use of SAMA, SABA Linked to Cardiovascular Events, Mortality in Asthma, COPD Monthly Specialist Briefings
Stay Connected
